MAP2K1 and colorectal adenocarcinoma: As PD98059, a MEK1 inhibitor, was not able to affect SPINK1 secretion or MEK and ERK phosphorylation, our data implicate MEK2 as a critical protein in the MAPK pathway in colorectal adenocarcinoma.